|
|
Article: Investor Alert for SIGA Technologies, Inc.
- Article from:
- M2 Presswire
- Article date:
- May 10, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-10 May 2007-Homeland Security News: Investor Alert for SIGA Technologies, Inc.(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:10052007
Say "ahhh" instead of "ow!" If development-stage SIGA Technologies has its way, painful vaccinations could become a thing of the past. The company is working on technology to administer vaccines directly through the body's mucus-lined surfaces -- such as the mouth and nose -- which are the usual entry points for infectious agents. It has development programs for vaccines, antivirals, and antibiotics to treat drug resistant infections; its its main focus, however, is on vaccines for bio-defense. In 2006 SIGA made ...
Related newspaper, magazine, and journal articles:
|
|
Article: SIGA Technologies to Present at the New York ...
Business Wire;
November 15, 2004 ;
700+ words
...NEW YORK -- SIGA Technologies, Inc. (Nasdaq:SIGA ... Kasten, SIGA's Chief Executive Officer, will present at the New ... nyssa.org/. About SIGA Technologies, Inc. SIGA Technologies is applying bacterial genomics ...
|
|